Globus Medical (GMED) Gross Profit (2011 - 2026)
Globus Medical posted quarterly Gross Profit of $525.8 million for Q1 2026, up 30.56% year-on-year from $402.7 million in Q1 2025, and down 6.99% on a QoQ basis from $565.3 million in Q4 2025.
Globus Medical (GMED) has 16 years of Gross Profit data on file, last reported at $525.8 million in Q1 2026.
- For the quarter ending Q1 2026, Gross Profit rose 30.56% year-over-year to $525.8 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 billion (up 38.3% YoY), and the FY2025 full-year result was $2.0 billion, up 33.51% from the prior year.
- Gross Profit for Q1 2026 stood at $525.8 million, down from $565.3 million in the prior quarter.
- Across five years, Gross Profit topped out at $565.3 million in Q4 2025 and bottomed at $171.4 million in Q1 2022.
- The 5-year median for Gross Profit is $355.2 million (2024), against an average of $339.4 million.
- The widest annual swing landed in 2022, when Gross Profit declined 0.54%; it then soared 77.39% in 2024.
- A 5-year view of Gross Profit shows it stood at $203.9 million in 2022, then jumped by 72.16% to $351.0 million in 2023, then gained by 12.19% to $393.9 million in 2024, then surged by 43.53% to $565.3 million in 2025, then decreased by 6.99% to $525.8 million in 2026.
- The last three Gross Profit figures came in at $525.8 million (Q1 2026), $565.3 million (Q4 2025), and $516.5 million (Q3 2025), per Business Quant data.